logo
EXCLUSIVE: Emergency warning as NHS Tayside prostate cancer patients wait 218 days for treatment

EXCLUSIVE: Emergency warning as NHS Tayside prostate cancer patients wait 218 days for treatment

The Couriera day ago

Men in Tayside are facing agonising delays of more than seven months between being referred with suspected prostate cancer and starting treatment, The Courier can reveal.
New figures show that two men who eventually received treatment in 2024 each waited 218 days — more than 30 weeks — from referral to the first step in their care.
The official target for cancer care in Scotland is that 95% of patients referred with an urgent suspicion of cancer should begin treatment within 62 days.
But in the first quarter of last year, just 17.6% of prostate cancer patients in NHS Tayside were treated on time.
While that figure improved slightly to 36.2% in the summer months, it deteriorated again to 22.6% in the final quarter.
Median waits reached 90 days between October and December – a full month beyond the national standard.
The data, released under Freedom of Information (FOI) legislation, covers only those patients who went on to be treated – meaning those still waiting or never treated at all are not counted.
The health board's performance is among the worst in Scotland and comes amid renewed focus on prostate cancer following the revelation that Sir Chris Hoy, the six-time Olympic gold medallist, is receiving treatment for the disease.
Sir Chris, 49, went public with his terminal prostate cancer diagnosis last year, after learning of his condition 'completely out of the blue' in September 2023.
He said the experience was 'a huge shock' and has since urged men not to delay getting tested.
'One simple check really can save lives,' he said.
The impact of his message was immediate.
NHS England reported a 672% increase in traffic to its prostate cancer symptom pages following his announcement.
Yet in Tayside, the data suggests patients are still being let down.
Labour MSP Michael Marra, who obtained the figures, described the delays as 'horrific'.
'They lay bare the life-threatening reality of this core cancer service under the SNP,' he said.
'Imagine being told you may well have prostate cancer, but you have to wait until the middle of January next year for an appointment.
'That is the reality for patients and families across Tayside, with waits of up to 218 days.
'The collapse of this service will mean months of anxious waits and lives lost that could have been saved with timely treatment.
'Constituents are contacting me telling of having to go private at great expense to have vital prostate surgery.'
Last year, we reported that NHS Tayside met the 62-day target in just 60% of all cancer cases — below the national average of 73.5%, and far below the 95% standard.
For urological cancers, the national figure was just 49%.
In a statement, NHS Tayside acknowledged that urology is its most challenged cancer specialty, citing long-standing workforce shortages.
'We recognise that waiting times are longer than we would like and understand this is distressing,' an NHS spokesperson said.
'We've recently appointed a new urology consultant and developed a cancer improvement plan, including more specialist nurses, expanded training, and new diagnostic equipment.'
Health Secretary Neil Gray said the Scottish Government was investing an additional £14 million to tackle cancer waiting times, with urology a key priority.
He said the funding would support over 150,000 extra appointments and procedures in 2025–26.
Prostate cancer is the most common cancer among men in Scotland, with around 4,300 new cases diagnosed each year, according to Prostate Cancer UK.
Risk increases with age, and men with a family history are at higher risk.
It is less common in men under 50 but can be aggressive when it does occur.
Last month, Sir Chris shared a positive update.
'I'm doing well,' he said. 'Most importantly, cancer's not the first thing I think about when I go to bed at night.'
You can track cancer waiting times in NHS Tayside here.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Medical staff who responded to Southport knife attacks honoured by King
Medical staff who responded to Southport knife attacks honoured by King

Western Telegraph

timea day ago

  • Western Telegraph

Medical staff who responded to Southport knife attacks honoured by King

Paul Smith, a senior paramedic team leader, treated victims at the scene where Bebe King, six, Elsie Dot Stancombe, seven, and Alice Dasilva Aguiar, nine, were murdered and 10 others injured at a Taylor Swift-themed dance class last July. Mr Smith, who works for the North West Ambulance Service, was awarded a British Empire Medal (BEM) for his services to the community in Merseyside after 'he put the needs of the injured before his own safety', the NHS said. I'd like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation Sir Jim Mackey, NHS chief executive Dr George Bramham, who was also a first responder, received the same honour. Martin Johnson and Elizabeth Parsons, who were part of the surgical team in theatre who treated people sent to Southport Hospital after the stabbings, have been given the same medals. Sir Jim Mackey, NHS chief executive, praised the staff for their 'incredible dedication and commitment in an awful situation'. Meanwhile, Reverend Martin Abrams, a spiritual care and chaplaincy manager, has been made a Member of the Order of the British Empire (MBE) for services to the community in Merseyside and west Lancashire. This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes Professor Bola Owolabi, NHS England He played a key role in the community after the horrors of the attacks, the health service said. Other NHS staff receiving honours include Professor Bola Owolabi, a GP and director of inequalities at NHS England, who was made a Commander of the Order of the British Empire (CBE) for her services to reducing health inequalities. Professor Owolabi said: 'This stands as a legacy of the work to address health inequalities by driving forward a powerful vision of exceptional quality healthcare for all, ensuring equitable access, excellent experience and optimal outcomes.' Sir Jim added: 'I want to give my heartfelt congratulations to all the people working in the NHS that have received honours, who work tirelessly everyday to care for their patients. 'I'd also like to recognise those staff who were involved in the response to the knife attack in Southport last summer. These awards rightly honour their incredible dedication and commitment in an awful situation. 'The NHS is made up of highly committed and dedicated people that work hard to give the best possible care to patients, and these honours recognise their skill, compassion and bravery.'

EXCLUSIVE: NHS Fife should be ‘grovelling and apologising' to trans row tribunal nurse, says Kemi Badenoch
EXCLUSIVE: NHS Fife should be ‘grovelling and apologising' to trans row tribunal nurse, says Kemi Badenoch

The Courier

timea day ago

  • The Courier

EXCLUSIVE: NHS Fife should be ‘grovelling and apologising' to trans row tribunal nurse, says Kemi Badenoch

NHS Fife should be 'grovelling' and saying sorry to the nurse at the centre of the transgender changing room row tribunal, Kemi Badenoch has said. The UK Tory leader is 'shocked' that the health board is yet to reach a settlement with Sandie Peggie, who works at Kirkcaldy's Victoria Hospital. Ms Peggie was suspended by NHS Fife after she told trans doctor Beth Upton that she felt uncomfortable at the two of them sharing a locker room. The A&E nurse sued the health board and the employment tribunal is set to resume next month after hearing two weeks of evidence in February. Ms Badenoch spoke exclusively to The Courier about the case after her speech to Conservative members at the party's conference in Edinburgh. The Tory chief was stunned when she first heard about the controversy. 'I was very shocked,' she said. 'What the NHS should be doing is grovelling and apologising, and settling very quickly. 'I am shocked that they continue to pursue this case. It is unconscionable.' Ms Badenoch said NHS Fife and other public bodies should take a close look at the Supreme Court's landmark recent gender ruling. Judges declared that the terms 'woman' and 'sex' in the equality act refer to biological women and biological sex. The Tory leader added: 'I think people are going to look back at this era, and wonder what was in the water that meant so many of these public authorities were messing around like this. 'We need to bring back common sense.' Ms Badenoch's remarks pile further pressure on the under-fire health board ahead of the tribunal reconvening. Last month NHS Fife was rebuked by a watchdog over its 'poor handling' of questions over how much the case has cost. Scottish Information Commissioner David Hamilton criticised the health board for failing to do any proper checks to find the information requested by several publishers, including The Courier. We had previously reported that NHS Fife was keeping the cost of the tribunal secret. A spokesperson for NHS Fife said: 'NHS Fife is not pursuing any legal claim in relation to this matter. 'Instead, it is the claimant in this case who is pursuing a legal claim against NHS Fife. 'The claimant has stated publicly that she is determined to continue with the legal action, as is her right. 'As the respondent, NHS Fife is required to continue to defend the case. 'As stated previously, the case involves a range of complex matters, including an internal investigation that was initiated following concerns raised by a member of staff. 'NHS Fife believes it had a responsibility to fully investigate such matters.'

World-first 'Trojan horse' drug to be given to blood cancer patients in England
World-first 'Trojan horse' drug to be given to blood cancer patients in England

ITV News

timea day ago

  • ITV News

World-first 'Trojan horse' drug to be given to blood cancer patients in England

Blood cancer patients in England will be among the first in the world to have access to a new 'Trojan horse' treatment, health officials have announced. Studies suggest the targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments. It is estimated that around 1,500 patients a year with multiple myeloma – an incurable cancer of the bone marrow – will benefit from the treatment. It comes after the National Institute for Health and Care Excellence (Nice) approved belantamab mafodotin, also known as Blenrep and made by GlaxoSmithKline, for NHS use. NHS England said that it is the first health system in the world to roll out the treatment. Officials said that the drug can now be offered to patients whose cancer has progressed or has not responded to another first-line treatment. The treatment, which is given as an infusion every three weeks along with other cancer drugs, is a type of antibody drug which targets and attaches to cancer cells. It has been dubbed a 'Trojan horse' treatment because it works by being taken into a cancer cell, before releasing a high concentration of a lethal molecule to destroy the cell from inside. 'Myeloma is an aggressive type of blood cancer, but we have seen a steady improvement in the outlook for patients over recent years as we have introduced new targeted therapies,' Professor Peter Johnson, NHS England's national clinical director for cancer, said. 'I am delighted that patients in England will be the first to benefit from this new treatment, which has the potential to keep cancer at bay for years longer, giving people the chance of more precious time with friends and family. 'This treatment could be life-changing for many patients and their families, and that's why it is so important that the NHS continues to secure quick access to the latest, innovative treatments like this, at affordable prices to the taxpayer.' Helen Knight, director of medicines evaluation at Nice, said: 'We're delighted that people in the UK will become among the first in the world to access belantamab mafodotin for this indication. 'This recommendation demonstrates our commitment to getting the best care to patients fast, while ensuring value for the taxpayer.' Trials have suggested that the treatment, in combination with bortezomib and dexamethasone, delayed progression of the disease by an average of three years, compared to just over a year for patients taking commonly used drug daratumumab along with the other treatments. Patient Paul Silvester, 60, from Sheffield, was diagnosed with myeloma in July 2023 and received treatment at the Royal Hallamshire Hospital. The first treatment he was given failed to stop his cancer from progressing so he was given belantamab mafodotin through an early access programme. 'I feel like this treatment has brought the party balloons back in the house. It has been amazing – within the first two or three weeks, after the first dose, I was in remission,' he said. 'It gives me quite a lot of confidence in the drugs and it makes me more optimistic about the future.'I've been feeling well and I'm still quite active – that's what's important in terms of your quality of life. 'One of my daughters is graduating from university in October and it's a goal for me to be there.' Shelagh McKinlay, director of research and advocacy at blood cancer charity Myeloma UK, said: 'It's fantastic to see the UK at the forefront of myeloma treatment. 'We have been working very hard for the last year to get this treatment approved and we know it will transform the lives of thousands of people with myeloma.' Health Minister Karin Smyth said: 'This groundbreaking therapy puts the NHS at the forefront of cancer innovation.'By harnessing cutting-edge 'trojan horse' technology, we're offering new hope to blood cancer patients across the country.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store